Literature DB >> 26260193

Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival.

Sebastian Christoph Schmid1, Tina Zahel2, Bernhard Haller3, Thomas Horn4, Ilja Metzger4, Konstantin Holzapfel2, Anna K Seitz4, Jürgen Erich Gschwend4, Margitta Retz4, Tobias Maurer4.   

Abstract

PURPOSE: Computed tomography (CT) is current standard-of-care for preoperative staging in patients with invasive bladder cancer before radical cystectomy (RC). There are only sparse data on the association between preoperative CT findings and postoperative survival of patients.
METHODS: We retrospectively evaluated preoperative CTs of 206 patients with invasive bladder cancer undergoing RC in an academic tertiary referral center. CTs were analyzed retrospectively for relative bladder wall thickness (BWT) and size of lymph nodes (LN). Associations between CT findings and risk of death from any cause (AC) as well as risk of death from bladder cancer (BC) were assessed by Kaplan-Meier estimates, cumulative incidence curves and multivariable Cox regression analysis.
RESULTS: The median follow-up was 40 months. Increased BWT was significantly correlated with higher risk of death (AC: HR 1.68; p = 0.043; BC: HR 2.00; p = 0.027), as well as LN with a size of 6-10 mm (AC: HR 2.13; p = 0.002; BC: HR 2.77; p = 0.002) and >10 mm (AC: HR 2.47; p = 0.018; BC: HR 3.66; p = 0.007) when compared to LN ≤ 5 mm.
CONCLUSION: Our data showed a significant correlation of bladder wall thickness and LN size with the risk of death. Also lymph nodes >5 mm but ≤ 10 mm (resp. ≤ 8 mm)-usually considered non-pathologic-were associated with a significantly worse prognosis. This information can be used to counsel patients preoperatively. It might also be useful for a risk-adapted approach in regard to neoadjuvant chemotherapy.

Entities:  

Keywords:  Bladder cancer; CT scan; Computed tomography; Computerized tomography; Cystectomy; Imaging; Prognosis; Survival

Mesh:

Year:  2015        PMID: 26260193     DOI: 10.1007/s00345-015-1654-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  22 in total

1.  Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases.

Authors:  Rocco Papalia; Giuseppe Simone; Rosario Grasso; Raffaele Augelli; Eliodoro Faiella; Salvatore Guaglianone; Roberto Cazzato; Riccardo Del Vescovo; Mariaconsiglia Ferriero; Bruno Zobel; Michele Gallucci
Journal:  BJU Int       Date:  2011-08-25       Impact factor: 5.588

2.  Use of nomograms for predictions of outcome in patients with advanced bladder cancer.

Authors:  Shahrokh F Shariat; Pierre I Karakiewicz; Guilherme Godoy; Seth P Lerner
Journal:  Ther Adv Urol       Date:  2009-04

3.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

Review 4.  Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States.

Authors:  Kirk A Keegan; Harras B Zaid; Sanjay G Patel; Sam S Chang
Journal:  Curr Urol Rep       Date:  2014-04       Impact factor: 3.092

5.  Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer.

Authors:  Stefan Tritschler; Clarissa Mosler; Derya Tilki; Alexander Buchner; Christian Stief; Anno Graser
Journal:  Urology       Date:  2012-03-23       Impact factor: 2.649

6.  Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.

Authors:  Tobias Maurer; Michael Souvatzoglou; Hubert Kübler; Katharina Opercan; Stefan Schmidt; Ken Herrmann; Jens Stollfuss; Gregor Weirich; Bernhard Haller; Jürgen E Gschwend; Markus Schwaiger; Bernd J Krause; Uwe Treiber
Journal:  Eur Urol       Date:  2011-12-14       Impact factor: 20.096

Review 7.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

Authors:  Marko Babjuk; Maximilian Burger; Richard Zigeuner; Shahrokh F Shariat; Bas W G van Rhijn; Eva Compérat; Richard J Sylvester; Eero Kaasinen; Andreas Böhle; Joan Palou Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2013-06-12       Impact factor: 20.096

8.  Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy.

Authors:  Giuseppe Simone; Marco Bianchi; Diana Giannarelli; Siamak Daneshmand; Rocco Papalia; Mariaconsiglia Ferriero; Salvatore Guaglianone; Steno Sentinelli; Renzo Colombo; Francesco Montorsi; Devis Collura; Giovanni Muto; Giacomo Novara; Rodolfo Hurle; Michael Rink; Margit Fisch; Hassan Abol-Enein; Gus Miranda; Mihir Desai; Inderbir Gill; Michele Gallucci
Journal:  World J Urol       Date:  2014-12-27       Impact factor: 4.226

Review 9.  MR imaging of the male pelvis.

Authors:  J O Barentsz; M R Engelbrecht; J A Witjes; J J de la Rosette; M van der Graaf
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

10.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Authors:  J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif
Journal:  Eur Urol       Date:  2013-12-12       Impact factor: 20.096

View more
  8 in total

Review 1.  Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy.

Authors:  Cory M Hugen; Vinay Duddalwar; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

Review 2.  Advances in Imaging in Prostate and Bladder Cancer.

Authors:  Abhishek Srivastava; Laura M Douglass; Victoria Chernyak; Kara L Watts
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

Review 3.  Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Authors:  Mohammad H Bagheri; Mark A Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A Malayeri; Piyush K Agarwal; Peter L Choyke; Les R Folio; Andrea B Apolo
Journal:  Urol Oncol       Date:  2017-05-12       Impact factor: 3.498

Review 4.  High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.

Authors:  Yihuan Luo; Xin Zhang; Meile Mo; Zhong Tan; Lanshan Huang; Hong Zhou; Chunqin Wang; Fanglin Wei; Xiaohui Qiu; Rongquan He; Gang Chen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Prognostic value of computed tomography characteristics for overall survival in patients with maxillary cancer.

Authors:  Ying Yuan; Jingbo Wang; Yingwei Wu; Guojun Li; Xiaofeng Tao
Journal:  BMC Cancer       Date:  2016-10-10       Impact factor: 4.430

6.  A glance at imaging bladder cancer.

Authors:  Ebru Salmanoglu; Ethan Halpern; Edouard J Trabulsi; Sung Kim; Mathew L Thakur
Journal:  Clin Transl Imaging       Date:  2018-05-16

7.  Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients.

Authors:  Dan-Ming Wei; Wen-Jie Chen; Rong-Mei Meng; Na Zhao; Xiang-Yu Zhang; Dan-Yu Liao; Gang Chen
Journal:  Respir Res       Date:  2018-08-13

8.  Computed-tomography based scoring system predicts outcome for clinical lymph node-positive patients undergoing radical cystectomy.

Authors:  Lennert Eismann; Severin Rodler; Alexander Tamalunas; Gerald Schulz; Friedrich Jokisch; Yannic Volz; Paulo Pfitzinger; Boris Schlenker; Christian Stief; Olga Solyanik; Alexander Buchner; Tobias Grimm
Journal:  Int Braz J Urol       Date:  2022 Jan-Feb       Impact factor: 1.541

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.